{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:03Z","timestamp":1786654083565,"version":"build-2736575974"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118230","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:37:29Z","timestamp":1783665449000},"page":"118230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting RIPK1 for the treatment of depression: From neuroinflammation to synaptic plasticity"],"prefix":"10.1016","volume":"252","author":[{"given":"Xiao-Qun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-3456","authenticated-orcid":false,"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118230_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116358","article-title":"Role of Semaphorin 3A in common psychiatric illnesses such as schizophrenia, depression, and anxiety","volume":"226","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117085","article-title":"Mechanisms of action of ubiquitin-specific proteases, particularly ubiquitin-specific proteases 7, 8, and 25, in depression treatment","volume":"239","author":"Zhang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118230_b0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/0113894501394957250818110931","article-title":"Betaine, a potential Therapeutic Alternative for the Treatment of Depression","volume":"26","author":"Zhang","year":"2025","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/0113894501298344240507080149","article-title":"GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective","volume":"25","author":"Fan","year":"2024","journal-title":"Curr Drug Targets"},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2174\/1570159X21666230407124146","article-title":"A Comprehensive Review on the Importance of MiRNA-206 in the Animal Model and Human Diseases","volume":"22","author":"Qi","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.857081","article-title":"KRIBB11: a Promising Drug that Promotes Microglial Process Elongation and Suppresses Neuroinflammation","volume":"13","author":"Su","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109126","article-title":"Innate immune stimulation prevents chronic stress-induced depressive and anxiogenic-like behaviors in female mice","volume":"111","author":"Hu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbi.2024.08.048","article-title":"The inflammatory underpinning of depression: an historical perspective","volume":"122","author":"Yirmiya","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2026.118230_b0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.redox.2016.08.006","article-title":"Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression","volume":"9","author":"Du","year":"2016","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","article-title":"Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target","volume":"19","author":"Mifflin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.bcp.2026.118230_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103750","article-title":"Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease","volume":"28","author":"Pati","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.bcp.2026.118230_b0060","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.immuni.2025.07.024","article-title":"Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflammation in Alzheimer's disease","volume":"58","author":"Song","year":"2025","journal-title":"Immunity"},{"issue":"41","key":"10.1016\/j.bcp.2026.118230_b0065","doi-asserted-by":"crossref","first-page":"E8788","DOI":"10.1073\/pnas.1714175114","article-title":"RIPK1 mediates a disease-associated microglial response in Alzheimer's disease","volume":"114","author":"Ofengeim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118230_b0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2017.06.003","article-title":"RIP1-RIP3-DRP1 pathway regulates NLRP3 inflammasome activation following subarachnoid hemorrhage","volume":"295","author":"Zhou","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12964-024-01796-3","article-title":"RIPK1 inhibition mitigates neuroinflammation and rescues depressive-like behaviors in a mouse model of LPS-induced depression","volume":"22","author":"Gong","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118230_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.773562","article-title":"Antidepressant Mechanism of Traditional Chinese Medicine Formula Xiaoyaosan in CUMS-Induced Depressed Mouse Model via RIPK1-RIPK3-MLKL Mediated Necroptosis based on Network Pharmacology Analysis","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.freeradbiomed.2025.03.014","article-title":"Astragalin alleviates lipopolysaccharide-induced depressive-like behavior in mice by preserving blood-brain barrier integrity and suppressing neuroinflammation","volume":"232","author":"Cao","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0092-8674(95)90072-1","article-title":"RIP: a novel protein containing a death domain that interacts with Fas\/APO-1 (CD95) in yeast and causes cell death","volume":"81","author":"Stanger","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118230_b0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcdb.2020.06.014","article-title":"RIPK protein kinase family: Atypical lives of typical kinases","volume":"109","author":"Cuny","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2015.01.001","article-title":"RIPK1 and RIPK3: critical regulators of inflammation and cell death","volume":"25","author":"Newton","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2026.118230_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106697","article-title":"Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis","volume":"189","author":"Shi","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.118230_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1492807","article-title":"Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review","volume":"18","author":"Shen","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2026.118230_b0125","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3389\/fonc.2020.01562","article-title":"Insight into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.bcp.2026.118230_b0130","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/hmg\/ddac046","article-title":"RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis","volume":"31","author":"Fortugno","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"25","key":"10.1016\/j.bcp.2026.118230_b0135","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41388-024-03040-1","article-title":"GSK3\u03b2 and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer","volume":"43","author":"Shan","year":"2024","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jtho.2024.11.003","article-title":"DSTYK Inhibition Sensitizes NSCLC to Taxane-based Chemotherapy","volume":"20","author":"Echepare","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118230_b0145","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220726","article-title":"DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity","volume":"219","author":"Valencia","year":"2022","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.118230_b0150","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41590-018-0188-x","article-title":"RIP kinases as modulators of inflammation and immunity","volume":"19","author":"He","year":"2018","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118230_b0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036368","article-title":"Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation","volume":"12","author":"Newton","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2026.118230_b0165","article-title":"Targeting RIPK1 kinase for modulating inflammation in human diseases","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0170","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160336","article-title":"Regulated necrosis-related molecule mRNA expression in humans and mice and in murine acute tissue injury and systemic autoimmunity leading to progressive organ damage, and progressive fibrosis","volume":"36","author":"Honarpisheh","year":"2016","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41467-025-67917-9","article-title":"Dynamic neutrophil-keratinocyte communication network centered on IL-36\/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis","volume":"17","author":"Jiang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118230_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2026.02.006","article-title":"Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1-mediated chronic inflammatory skin diseases","author":"Jargosch","year":"2026","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40478-021-01236-0","article-title":"RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury","volume":"9","author":"Wehn","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14449","article-title":"Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia-derived neuroinflammation","volume":"30","author":"Zhou","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.str.2013.01.016","article-title":"Structural basis of RIP1 inhibition by necrostatins","volume":"21","author":"Xie","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2026.118230_b0200","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1038\/ncomms14329","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0205","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-020-15466-8","article-title":"Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation","volume":"11","author":"Laurien","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118230_b0215","article-title":"RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118230_b0220","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s12276-022-00847-4","article-title":"The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era","volume":"54","author":"Ju","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"45","key":"10.1016\/j.bcp.2026.118230_b0225","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1073\/pnas.1715742114","article-title":"PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.bcp.2026.118230_b0230","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1002\/j.1460-2075.1996.tb01007.x","article-title":"RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas\/APO-1-initiated apoptosis","volume":"15","author":"Ting","year":"1996","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","article-title":"The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis","volume":"150","author":"Li","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0240","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1042\/BST20220535","article-title":"The role of RHIM in necroptosis","volume":"50","author":"Riebeling","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0245","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","article-title":"MK2 Phosphorylates RIPK1 to prevent TNF-Induced Cell Death","volume":"66","author":"Jaco","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-00406-w","article-title":"Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis","volume":"8","author":"Geng","year":"2017","journal-title":"Nat. Commun."},{"issue":"6844","key":"10.1016\/j.bcp.2026.118230_b0255","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"issue":"7788","key":"10.1016\/j.bcp.2026.118230_b0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2026.118230_b0265","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41419-018-0770-z","article-title":"Parkin regulates NF-\u03baB by mediating site-specific ubiquitination of RIPK1","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bcp.2026.118230_b0270","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni.1638","article-title":"Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses","volume":"9","author":"Ermolaeva","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbapap.2012.08.013","article-title":"Formation of the death domain complex between FADD and RIP1 proteins in vitro","volume":"1834","author":"Park","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0280","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1038\/s41467-020-19935-y","article-title":"Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0285","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.jmedchem.3c02102","article-title":"From hit to Lead: Structure-based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118230_b0290","article-title":"Electric dipole moment drives the dynamics of theTNFR1 complex I signalosome","author":"Liu","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0295","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1038\/s41467-022-34692-w","article-title":"Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0300","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.03.032","article-title":"The Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling complex","volume":"173","author":"Mompe\u00e1n","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0305","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41467-024-51303-y","article-title":"The structure of mouse RIPK1 RHIM-containing domain as a homo-amyloid and in RIPK1\/RIPK3 complex","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0310","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cmet.2025.05.014","article-title":"RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation","volume":"37","author":"Chen","year":"2025","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11064-025-04448-1","article-title":"From RIPK1 to Necroptosis: Pathogenic Mechanisms in Neurodegenerative Diseases","volume":"50","author":"Kang","year":"2025","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13543776.2023.2195548","article-title":"Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)","volume":"33","author":"Xu","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2026.118230_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0330","article-title":"Toxicity of Necrostatin-1 in Parkinson's Disease Models","volume":"9","author":"Alegre-Cort\u00e9s","year":"2020","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.118230_b0335","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.biopha.2017.09.063","article-title":"Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS\/MS and the study of its pharmacokinetics and bioavailability","volume":"95","author":"Geng","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0340","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118230_b0345","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1038\/cddis.2012.176","article-title":"Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models","volume":"3","author":"Takahashi","year":"2012","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23081946","article-title":"Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry","volume":"23","author":"Miku\u0161","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0355","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/cts.13317","article-title":"Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients","volume":"15","author":"Vissers","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0360","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13690","article-title":"Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants","volume":"17","author":"Hincelin-Mery","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11481-025-10208-3","article-title":"RIPK1: a Promising Target for intervention Neuroinflammation","volume":"20","author":"Yan","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116496","article-title":"Current therapy in amyotrophic lateral sclerosis (ALS): a review on past and future therapeutic strategies","volume":"272","author":"Wei","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"10130","key":"10.1016\/j.bcp.2026.118230_b0375","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0380","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2026.118230_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113484","article-title":"Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors","volume":"220","author":"Xia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118230_b0390","unstructured":"A.A. Estrada, J.A. Feng, B. Fox, C.P. Leslie, J.P. Lyssikatos, A. Pozzan, Z.K. Sweeney, J. de Vicente Fidalgo, Compounds, compositions and methods, Google Patents, 2017."},{"issue":"8","key":"10.1016\/j.bcp.2026.118230_b0395","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1007\/s12325-025-03255-y","article-title":"A Randomized phase I Trial evaluating Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eclitasertib, a RIPK1 Inhibitor, in Healthy Participants","volume":"42","author":"Farenc","year":"2025","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-024-02670-z","article-title":"Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study","volume":"25","author":"Clot","year":"2024","journal-title":"Respir. Res."},{"issue":"22","key":"10.1016\/j.bcp.2026.118230_b0405","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1021\/acs.jmedchem.2c01518","article-title":"Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities","volume":"65","author":"Shi","year":"2022","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.365","article-title":"Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers","volume":"5","author":"Weisel","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bcp.2026.118230_b0415","article-title":"RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection","volume":"18","author":"Silva-Llanes","year":"2024","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0420","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000680","article-title":"A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis","volume":"8","author":"Weisel","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-021-02468-0","article-title":"A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis","volume":"23","author":"Weisel","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0430","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13555-024-01097-0","article-title":"Inhibition of Receptor-Interacting Protein Kinase1 in Chronic Plaque Psoriasis: a Multicenter, Randomized, Double-blind, Placebo-Controlled Study","volume":"14","author":"Ludbrook","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"10.1016\/j.bcp.2026.118230_b0435","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is Rheumatoid Arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.bcp.2026.118230_b0440","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.bcp.2026.118230_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116414","article-title":"Inhibition of LRRK2 alleviates LPS-induced hippocampal pericyte loss and depressive-like behaviors through suppressing the RIPK1-mediated necroptosis pathway","volume":"175","author":"Liu","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41392-023-01519-z","article-title":"Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0455","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bcp.2026.118230_b0460","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/cts.13607","article-title":"A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers","volume":"16","author":"Jones","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0465","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41418-020-00629-3","article-title":"Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death","volume":"28","author":"Kist","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118230_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120485","article-title":"Exploring the neuroprotective properties of musk against high-altitude cerebral edema: Unveiling the mechanisms via TNF-\u03b1\/RIPK1 pathway regulation and necroptosis inhibition","volume":"354","author":"Han","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0475","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10495-017-1358-2","article-title":"RIPK1\/RIPK3\/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death","volume":"22","author":"Chen","year":"2017","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0480","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","article-title":"The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation","volume":"81","author":"Hsu","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0485","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"issue":"7534","key":"10.1016\/j.bcp.2026.118230_b0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bcp.2026.118230_b0495","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1073\/pnas.93.24.13973","article-title":"The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex","volume":"93","author":"Shu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bcp.2026.118230_b0500","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41418-024-01355-w","article-title":"LUBAC enables tumor-promoting LT\u03b2 receptor signaling by activating canonical NF-\u03baB","volume":"31","author":"Chen","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0505","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s44318-024-00291-2","article-title":"STING induces HOIP-mediated synthesis of M1 ubiquitin chains to stimulate NF-\u03baB signaling","volume":"44","author":"Fischer","year":"2025","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0510","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/15548627.2024.2443945","article-title":"Linear ubiquitination at damaged lysosomes induces local NFKB activation and controls cell survival","volume":"21","author":"Zein","year":"2025","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0515","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","article-title":"TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains","volume":"15","author":"Kanayama","year":"2004","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118230_b0520","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cub.2007.01.027","article-title":"Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling","volume":"17","author":"O'Donnell","year":"2007","journal-title":"Curr. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2026.118230_b0525","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/emboj.2012.240","article-title":"A20 inhibits LUBAC-mediated NF-\u03baB activation by binding linear polyubiquitin chains via its zinc finger 7","volume":"31","author":"Verhelst","year":"2012","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bcp.2026.118230_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076841","article-title":"CYLD deubiquitinates RIP1 in the TNF\u03b1-induced necrosome to facilitate kinase activation and programmed necrosis","volume":"8","author":"Moquin","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0535","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2011.09.003","article-title":"RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts","volume":"44","author":"Green","year":"2011","journal-title":"Mol. Cell"},{"issue":"6281","key":"10.1016\/j.bcp.2026.118230_b0540","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf2154","article-title":"Programmed necrosis in inflammation: Toward identification of the effector molecules","volume":"352","author":"Wallach","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0545","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","article-title":"TNF-alpha induces two distinct caspase-8 activation pathways","volume":"133","author":"Wang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118230_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114676","article-title":"Aerobic exercise modulates RIPK1-mediated MAP3K5\/JNK and NF-\u03baB pathways to suppress microglia activation and neuroinflammation in the hippocampus of D-gal-induced accelerated aging mice","volume":"286","author":"Liu","year":"2024","journal-title":"Physiol. Behav."},{"issue":"10","key":"10.1016\/j.bcp.2026.118230_b0555","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s11064-023-03959-z","article-title":"TAK1 Reduces Surgery-induced Overactivation of RIPK1 to Relieve Neuroinflammation and Cognitive Dysfunction in Aged Rats","volume":"48","author":"Zhang","year":"2023","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0560","doi-asserted-by":"crossref","first-page":"807","DOI":"10.14336\/AD.2018.0728","article-title":"Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3\/MLKL Signaling","volume":"10","author":"Deng","year":"2019","journal-title":"Aging Dis."},{"issue":"11","key":"10.1016\/j.bcp.2026.118230_b0565","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","article-title":"Activation of necroptosis in multiple sclerosis","volume":"10","author":"Ofengeim","year":"2015","journal-title":"Cell Rep."},{"issue":"6299","key":"10.1016\/j.bcp.2026.118230_b0570","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.aaf6803","article-title":"RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS","volume":"353","author":"Ito","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bcp.2026.118230_b0575","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in Alzheimer's disease","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"19","key":"10.1016\/j.bcp.2026.118230_b0580","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.7150\/thno.62376","article-title":"TNF-\u03b1-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109112","article-title":"RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis","volume":"35","author":"Zelic","year":"2021","journal-title":"Cell Rep."},{"issue":"9\u201310","key":"10.1016\/j.bcp.2026.118230_b0590","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000505132","article-title":"Lipopolysaccharide-Induced Depression-like Behaviors is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative stress","volume":"105","author":"Qiu","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2026.118230_b0595","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898955","article-title":"A review for the pharmacological effects of paeoniflorin in the nervous system","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0600","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.829966","article-title":"Indole-3-Carbinol Selectively Prevents Chronic Stress-Induced Depression-but not Anxiety-like Behaviors via Suppressing Pro-Inflammatory Cytokine Production and Oxido-Nitrosative stress in the Brain","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0605","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/13880209.2021.1876101","article-title":"Eucalyptol ameliorates early brain injury after subarachnoid haemorrhage via antioxidant and anti-inflammatory effects in a rat model","volume":"59","author":"Xu","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bcp.2026.118230_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106133","article-title":"CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease","volume":"177","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0615","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118230_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152923","article-title":"Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation","volume":"461","author":"Shao","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2026.118230_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111990","article-title":"Hydrogen sulfide regulates macrophage polarization and necroptosis to accelerate diabetic skin wound healing","volume":"132","author":"He","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113936","article-title":"Inhibition of ZFP281\/ZNF281-RIPK1\/RIPK3\/MLKL signaling in hepatocytes by pterostilbene relieves hepatic lipometabolic disorder and inflammation in non-alcoholic steatohepatitis","volume":"146","author":"Lu","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030417","article-title":"RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118230_b0640","article-title":"Necroptotic kinases are involved in the reduction of depression-induced astrocytes and fluoxetine's inhibitory effects on necroptotic kinases","volume":"13","author":"Zeb","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578643","article-title":"RIPK3-MLKL dependent necroptosis mediates depressive-like behavior by facilitating neuroinflammation","volume":"405","author":"Zheng","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2026.118230_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112380","article-title":"Yueju-Ganmaidazao Decoction confers rapid antidepressant-like effects and the involvement of suppression of NMDA\/NO\/cGMP signaling","volume":"250","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"16","key":"10.1016\/j.bcp.2026.118230_b0655","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1111\/bph.15847","article-title":"Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up-regulating hippocampal PACAP signalling","volume":"179","author":"Zhang","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118230_b0660","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2026.01.014","article-title":"Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer's disease risk factors","volume":"59","author":"Xie","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118230_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123614","article-title":"An antioxidative injectable chitosan hydrogel based on tannic acid modified dialdehyde polyurethane nano-crosslinker targeting RIPK1 to regulate neuroinflammation for amelioration of Parkinson's disease","volume":"325","author":"Xu","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118230_b0670","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1015035","article-title":"Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.03.033","article-title":"Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy","volume":"357","author":"Zhou","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0680","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s11064-021-03505-9","article-title":"Necrostatin-1 against Sevoflurane-Induced Cognitive Dysfunction Involves Activation of BDNF\/TrkB Pathway and Inhibition of Necroptosis in Aged Rats","volume":"47","author":"Yin","year":"2022","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0685","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2026.118230_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117375","article-title":"Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo","volume":"320","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.118230_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178468","article-title":"AdipoRon ameliorates anxiety- and depression-like behaviors in chronic restraint-stressed mice via AMPK-PPAR\u03b1-BDNF-TrkB signaling","volume":"1011","author":"Li","year":"2026","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118230_b0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031613","article-title":"Molecular Mechanisms of Accelerated Ageing in Geriatric Depression: Interplay of Telomere Attrition, Mitochondrial Dysfunction and Cellular Senescence","volume":"27","author":"Revi Shanker","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118230_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101805","article-title":"Major depression and the biological hallmarks of aging","volume":"83","author":"Lorenzo","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0710","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/s41467-020-16312-7","article-title":"Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0715","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cell.2018.07.041","article-title":"TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging","volume":"174","author":"Xu","year":"2018","journal-title":"Cell"},{"issue":"Pt A","key":"10.1016\/j.bcp.2026.118230_b0720","article-title":"Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus","volume":"318","author":"Jiao","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"6747","key":"10.1016\/j.bcp.2026.118230_b0725","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.abb6748","article-title":"Enhanced ERK activity extends ketamine's antidepressant effects by augmenting synaptic plasticity","volume":"388","author":"Ma","year":"2025","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bcp.2026.118230_b0730","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cmet.2025.08.010","article-title":"Hepatic acetyl-CoA metabolism modulates neuroinflammation and depression susceptibility via acetate","volume":"37","author":"Cao","year":"2025","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bcp.2026.118230_b0735","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/s41380-020-0692-x","article-title":"Programmed cell death 4 as an endogenous suppressor of BDNF translation is involved in stress-induced depression","volume":"26","author":"Li","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bcp.2026.118230_b0740","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1080\/15384101.2020.1749472","article-title":"Overexpressed microRNA-494 represses RIPK1 to attenuate hippocampal neuron injury in epilepsy rats by inactivating the NF-\u03baB signaling pathway","volume":"19","author":"Qi","year":"2020","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bcp.2026.118230_b0745","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41523-021-00261-5","article-title":"RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis","volume":"7","author":"Yin","year":"2021","journal-title":"npj Breast Cancer"},{"issue":"18","key":"10.1016\/j.bcp.2026.118230_b0750","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.7150\/jca.46172","article-title":"Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer","volume":"11","author":"Park","year":"2020","journal-title":"J. Cancer"},{"issue":"6404","key":"10.1016\/j.bcp.2026.118230_b0755","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.aar2641","article-title":"Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation","volume":"361","author":"Cuchet-Louren\u00e7o","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2026.118230_b0760","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:21:03Z","timestamp":1786652463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":152,"alternative-id":["S0006295226005691"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118230","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting RIPK1 for the treatment of depression: From neuroinflammation to synaptic plasticity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118230"}}